SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Continucare (CNU) depr. PSYCLE sm buy again ?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stitch who wrote (9)3/27/1998 10:37:00 AM
From: Worswick  Read Replies (1) of 17
 
They have $42-$57 million in cash: 13 million shares divided by = $50 million $3.84 per share.

This is an aquisitions program... CNU. In an area where not many people have tried to build from a central core of practices... in the rehab sector of medicine. Great economies of scale.

I sound like a hypster but I went out and bought the stock based on only one analyst following the story: and, no retail coverage or hype to date pumping up the stock. S&P on March 5 indicated there were only 100 shareholdrs. The beginnings of a company with lots of cash for acquisitions....leader of the board is the man who built the largest generic drug company around.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext